Figure 7

![Figure 7: Supporting evidence from the review of telogen effluvium associated with COVID-19 and the therapeutic potential of adipose-derived mesenchymal stem cells. The data contextualize hair loss as a post-COVID sequela.]()

> Source: Pietro Gentile "Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication o." *International journal of molecular sciences*, 2022. PMID: [36012383](https://pubmed.ncbi.nlm.nih.gov/36012383/)

<figure>
  <img src="" alt="Supporting evidence from the review of telogen effluvium associated with COVID-19 and the therapeutic potential of adipose-derived mesenchymal stem cells. The data contextualize hair loss as a post-COVID sequela." />
  <figcaption>Figure 7. Supporting evidence from the review of telogen effluvium associated with COVID-19 and the therapeutic potential of adipose-derived mesenchymal stem cells. The data contextualize hair loss as a post-COVID sequela.<br>  Source: Pietro Gentile "Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication o." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36012383/">36012383</a></figcaption>
</figure>